The Federal Trade Commission said the three companies' practices have artificially inflated list prices for insulin.
While U.S. District Judge Adrienne Nelson mulls over details in the Federal Trade Commission-Kroger, Albertsons merger trial, ...
Although a court decision could still be weeks away, Wall Street analysts and investors are predicting the deal with Albertsons won’t get approved.